DIREVO Announces Transfer Of Patents From Evotec DIREVO Biotech AG announced that it has entered into an agreement with Evotec under which Evotec will transfer certain patents to DIREVO that are currently licensed by DIREVO. Such patents protect key components of DIREVO's unique and proven protein/strain engineering platform. Using this platform, DIREVO develops products both independently and with global leaders such as AstraZeneca/MedImmune and Pfizer, as well as Danisco/Genencor and Nestlé.
Source: www.medicalnewstoday.com
# posted by Network @ 3:00 AM
